Evidence map›Paper›PMID 40358805›Full record

ArticleJournal of neuro-oncology2025

Predictors of return to work following surgery in patients with glioblastoma: a retrospective multicenter study.

Harshvardhan G Iyer, Ogechukwu K Ariwodo, Chase Mckevitt, Paola Suarez Meade, Lina Marenco-Hillembrand, Andrea Otamendi-Lopez, Leonardo José Monteiro de Macêdo Filho, Steven S Rosenfeld, Christine Cordova, Jennifer L Peterson and 12 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Harshvardhan G Iyer *Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Ogechukwu K Ariwodo *Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Chase MckevittDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Paola Suarez MeadeDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Lina Marenco-HillembrandDepartment of Neurological Surgery, University of Iowa Hospitals, Iowa City, IA, USA.
Andrea Otamendi-LopezDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Leonardo José Monteiro de Macêdo FilhoDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Steven S RosenfeldDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Christine CordovaDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Jennifer L PetersonDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.
Daniel M TrifilettiDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.
David S SabsevitzDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Ian F ParneyDepartment of Neurological Surgery, Mayo Clinic, Rochester, MN, USA.
Terry C BurnsDepartment of Neurological Surgery, Mayo Clinic, Rochester, MN, USA.
Fredric B MeyerDepartment of Neurological Surgery, Mayo Clinic, Rochester, MN, USA.
Bernard R BendokDepartment of Neurological Surgery, Mayo Clinic, Phoenix, AZ, USA.
Krishna ChandanDepartment of Neurological Surgery, Mayo Clinic, Phoenix, AZ, USA.
Rich ByrneDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Victoria ClarkDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Alfredo Quinones-HinojosaDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Wendy J ShermanDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Kaisorn L ChaichanaDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA. chaichana.kaisorn@mayo.edu.ORCID http://orcid.org/0000-0002-9775-8912

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWhile clinical outcomes of glioblastoma (GBM) are well-documented, its socio-economic impact, particularly on return to work (RTW) remains unexplored. In this study we aimed to identify the predictors of RTW at 6 months postoperatively in patients undergoing GBM treatment and to assess its association with post-operative neurological deficits and median overall survival (mOS).

methodsWe retrospectively studied 106 adults with pre-operative employment, undergoing primary GBM resection or biopsy at three tertiary centers. RTW at 3 and 6 months postoperatively were assessed using univariate and multivariate analyses.

resultsAfter 6 months 33 patients (33.1%) were able to RTW. Factors associated with lower odds of RTW included female sex (p = 0.039), Karnofsky Performance Scale (KPS) < 80 at 2 weeks (p = 0.034), and 3 months post-operatively (p = 0.0001), right handedness (p = 0.038), and subtotal resection (p = 0.042). On multivariate analysis female sex (OR 0.238, 95% CI 0.077-0.733, p = 0.012) and three-month postoperative KPS < 80 (OR 0.019, 95% CI 0.001-0.0293, p = 0.004) were the least likely to RTW at six months. Acute postoperative motor (p = 0.047), gait (p = 0.008) and cognitive deficits (p = 0.048) and persistent motor (p = 0.017), gait (p = 0.033) and language (p = 0.026) deficits were all associated with lesser RTW. Patients who returned to work had significantly longer mOS (21.44, p < 0.001).

conclusionsRTW at 6 months post GBM Surgery corelates with improved mOS. Female sex and lower post-operative KPS scores were the strongest predictors of reduced RTW.

Indexed as

Brain NeoplasmsGlioblastomaReturn to WorkAdultAgedFemaleFollow-Up StudiesHumansKarnofsky Performance StatusMaleMiddle AgedNeurosurgical ProceduresPrognosisRetrospective StudiesAdult type gliomasEmploymentGlioblastomaQuality of lifeReturn to workSurvival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.